Becton, Dickinson and Company (BDX) , popularly known as BD, is well-poised for growth in the coming quarters, courtesy of its series of product launches over the past few months. The optimism led by a solid first-quarter fiscal 2024 performance and a few strategic deals are expected to contribute further. However, macroeconomic concerns and stiff competition persist.Over the past year, this Zacks Rank #3 (Hold) stock has gained 3.5% compared with the 18.1% rise of the industry and 32.9% growth of the S&P 5 ...

Becton, Dickinson and Company (BDX) , popularly known as BD, recently announced the enrollment of the first patient in the investigational device exemption (IDE) study, AGILITY, which aims to evaluate the efficacy and safety of the BD Vascular Covered Stent in treating peripheral arterial disease (PAD).The first patient in the AGILITY study was enrolled at Trinity Medical Center in Bettendorf, Iowa, by Dr. Nicolas Shammas, Interventional Cardiologist, Cardiovascular Medicine, PLLC.Price PerformanceFor the p ...

Dumpster diving can be fun! One man’s trash is another’s treasure, particularly when investing. Stocks tossed into the trash and trading at 52-week lows can many times turn into real jewels for your portfolio.Of course, you should use caution. Just because a stock is down does not make it a buy. Cheap stocks are often cheap for a reason. You can’t readily fix them because something is wrong with the business. Avoid those stocks at all costs. You don’t want your portfolio to be like an episode of TV’s Hoarde ...

First Patient Enrollment in AGILITY Study Begins Investigations of Safety and Effectiveness of BD Vascular Covered Stent for Treatment of PADFRANKLIN LAKES, N.J., March 4, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the enrollment of the first patient in the investigational device exemption (IDE) study, "AGILITY," which will assess the safety and effectiveness of the BD Vascular Covered Stent for the treatment of Periphera ...

Natali_Mis/iStock via Getty Images I worried about Becton, Dickinson and Company’s (NYSE:BDX) weak China growth as discussed in my introductory article. On February 1, BD released their Q1 FY24. China declined 5.3% year-over-year, and now the market only represents 6.4% of group revenue. Other major challenges, including the Alaris pump and Covid comparisons, are starting to get normalized, and the stock price is undervalued; therefore, I upgrade the rating from ‘Hold to ‘Buy’ with a fair value of $250 ...

The stock market bulls are charging right now. The Federal Reserve appears set to lower interest rates this year, which could stoke equity markets. Meanwhile, the emergence of AI has powered tech stocks higher.However, some analysts are worried that this rally could come crashing down. Given high valuation multiples on many leading momentum stocks right now, this is a tricky time to put capital to work.The good news, though, is that there are still plenty of good investment opportunities for long-term inves ...

FRANKLIN LAKES, N.J., Feb. 27, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Dave Hickey has informed the company of his intent to retire from BD, effective July 1. Hickey is currently executive vice president and president of the Life Sciences segment for BD, a position he has held since January 2021. Prior to his current role, Hickey was president of Integrated Diagnostic Solutions from 2019 to 2021, and president of ...

Becton, Dickinson and Company (BDX) , popularly known as BD and Camtech Health, recently announced their strategic collaboration to uplift cervical cancer screening for women in Singapore by providing them the first-ever option to self-collect a sample amidst the privacy of their own home.The partnership is intended to raise the percentage of cervical cancer screening in Singapore, where the present screening rate is less than half of eligible women.Price PerformanceFor the past six months, BDX’s shares hav ...

First-Ever Program in the Country to Offer At-Home Self-Collection of Samples for HPV TestingSINGAPORE, Feb. 21, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a strategic partnership with Camtech Health, a digital health company focused on at-home health testing, to advance cervical cancer screening by offering the first-ever option for women in Singapore to self-collect a sample in the privacy of their own home. BD annou ...

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Becton Dickinson (BDX) or West Pharmaceutical Services (WST) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our ...